Effect of candesartan on cause-specific mortality in heart failure patients: The candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program (vol 110, pg 2180, 2004)

被引：0
|
作者：
Solomon
机构：
来源：
CIRCULATION | 2005年 / 111卷 / 03期
关键词：
D O I：
10.1161/01.CIR.0000155486.26868.C9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [41] Candesartan vs Losartan and Mortality in Patients With Heart Failure
    Fruhwald, Friedrich
    Pieske, Burkert
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (15): : 1540 - 1541
  • [42] The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Gerstein, Hertzel C.
    Swedberg, Karl
    Carlsson, Jonas
    McMurray, John J. V.
    Michelson, Eric L.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Yusuf, Salim
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1699 - 1704
  • [43] Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure:: baseline characteristics of patients in the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    McMurray, J
    Östergren, J
    Pfeffer, M
    Swedberg, K
    Granger, C
    Yusuf, S
    Held, P
    Michelson, E
    Olofsson, B
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (03) : 261 - 270
  • [44] Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme
    Hawkins, NM
    Wang, DL
    Pocock, SJ
    McMurray, JJV
    Pfeffer, MA
    Swedberg, K
    Granger, CB
    Yusuf, S
    Dunn, FG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 146A - 146A
  • [45] Atrial fibrillation carries similar risks in heart failure irrespective of ejection fraction-results from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)
    Olsson, L. G.
    Swedberg, K.
    Granger, C. B.
    Michelson, E.
    McMurray, J. J. V.
    Puuh, M.
    Yusuf, S.
    Pfeffer, M. A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 378 - 379
  • [46] Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme
    Chang, Su Min
    Granger, Christopher B.
    Johansson, Peter A.
    Kosolcharoen, Peter
    McMurray, John J. V.
    Michelson, Eric L.
    Murray, David R.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Solomon, Scott D.
    Swedberg, Karl
    Yusuf, Salim
    Dunlap, Mark E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (07) : 738 - 745
  • [47] Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme
    Jackson, C. E.
    Solomon, S. D.
    Gerstein, H. C.
    Andersson, S.
    Michelson, E. L.
    Granger, C. B.
    Swedberg, K.
    Pfeffer, M. A.
    Yusuf, S.
    Mcmurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2009, 30 : 876 - 876
  • [48] Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Olsson, Lars G.
    Swedberg, Karl
    Ducharme, Anique
    Granger, Christopher B.
    Michelson, Eric L.
    McMurray, John J. V.
    Puu, Margareta
    Yusuf, Salim
    Pfeffer, Marc A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) : 1997 - 2004
  • [49] Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
    Eklind-Cervenka, Maria
    Benson, Lina
    Dahlstrom, Ulf
    Edner, Magnus
    Rosenqvist, Marten
    Lund, Lars H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (02): : 175 - 182
  • [50] Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
    Hasenoehrl, Norbert
    JOURNAL FUR KARDIOLOGIE, 2011, 18 (3-4): : 108 - 109
12345